Ajanta Pharma logo

Ajanta Pharma share news, announcements and annual reports

NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap

Ajanta Pharma Limited · Face value ₹2 · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,508.80up ₹49.10 (1.42%)BSE ₹3,512.40

Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.

30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50

52-week range of traded prices to 30 Oct 2026
₹2,430.00Low, 30 Oct 2025₹3,796.00High, 18 Aug 2026
Market cap
₹43,846 Cr236th largest listed
P/E
34.72
P/B
9.02
Dividend yield
1.71%
ROE
27.5%
ROCE
30.3%
Debt to equity
0.02
Volume, NSE
9,52,55826.6% delivered

Ajanta Pharma shareholding disclosures

196 filed, newest first. Page 4 of 4.

  1. Apr 2012

  2. Mar 2012

  3. Feb 2012

  4. Jan 2012

  5. Dec 2011

  6. Nov 2011

  7. Oct 2011

  8. Apr 2011

    • 30 Apr · Disclosure

      Board of Directors has approved the Employee Stock Option Scheme for 1,80,000 equity shares, 1.5% of the current equity subject to the approval of the shareholders in the ensuing Annual General Meeting to be held on July 08, 2011.
  9. Apr 2010

    • 8 Apr · Disclosure

      Disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  10. Aug 2009

    • 11 Aug · Disclosure

      Regulation 8A(4) of SEBI (SAST) Regulations, 1997 giving details of shares revoked alongwith the respective dates by the promoters. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.